预测lacosamide度以支持在怀孕期间的剂量优化
Jessica M Barry1, Sílvia M Illamola1, Page B Pennell2
1Department of Experimental and Clinical Pharmacology, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA.
这项研究开发了一种基于妊娠生理学的药理动力学模型,以预测孕妇暴露于lacosamide的情况. 研究结果表明,需要进行剂量调整,以保持怀孕期间的治疗度.
科学领域:
- 药理动力学 药理动力学
- 怀孕 怀孕 怀孕 怀孕
- 药物治疗 药物治疗
背景情况:
- 拉科萨米德是一种在怀孕期间使用的抗药.
- 准确预测药物暴露对孕产妇和胎儿健康至关重要.
- 基于生理学的药理动力学 (PBPK) 模型可以模拟特定人群中的药物行为.
研究的目的:
- 开发和验证lacosamide的怀孕PBPK模型.
- 量化和预测整个怀孕期间西胺暴露的变化.
- 以告知潜在的剂量调整,以维持治疗度.
主要方法:
- 使用文献数据,为非怀孕和怀孕的成年人构建PBPK模型.
- 经过验证的模型与观察性研究中的人体血度数据对比.
- 进行了模拟,以评估跨妊娠年龄的lacosamide药理动力学,并探索影响因素.
主要成果:
- 该模型准确地描述了怀孕和非怀孕的成年人中的lacosamide度.
- 在怀孕40周时,山胺清除量增加了48.2%.
- 模拟表明Cmax下降了30%,并支持每日50毫克的剂量增加以维持怀孕前的水平.
结论:
- 模拟的lacosamide度变化与观察数据保持一致.
- PBPK模型支持怀孕期间治疗药物监测和剂量调整的需要.
- 这种方法可以帮助保持lacosamide在孕妇患者的疗效.
更多相关视频
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:04Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
相关概念视频
Factors Affecting Drug Response: Overview
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
